Cargando…
Risk factors for febrile urinary tract infection in boys with posterior urethral valves
OBJECTIVE: Boys with posterior urethral valves (PUV) present an increased risk of febrile urinary tract infection (fUTI). Identifying specific risk factors could allow for tailoring UTI prevention. The aim of this study was to use the data from the CIRCUP randomized controlled trial data to identify...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515483/ https://www.ncbi.nlm.nih.gov/pubmed/36186628 http://dx.doi.org/10.3389/fped.2022.971662 |
_version_ | 1784798491722121216 |
---|---|
author | Harper, Luke Botto, Nathalie Peycelon, Matthieu Michel, Jean-Luc Leclair, Marc-David Garnier, Sarah Clermidi, Pauline Arnaud, Alexis P. Dariel, Anne-Laure Dobremez, Eric Faure, Alice Fourcade, Laurent Boudaoud, Nadia Chaussy, Yann Collin, Fideline Huiart, Laetitia Ferdynus, Cyril Bocquet, Valery Sauvat, Frederique |
author_facet | Harper, Luke Botto, Nathalie Peycelon, Matthieu Michel, Jean-Luc Leclair, Marc-David Garnier, Sarah Clermidi, Pauline Arnaud, Alexis P. Dariel, Anne-Laure Dobremez, Eric Faure, Alice Fourcade, Laurent Boudaoud, Nadia Chaussy, Yann Collin, Fideline Huiart, Laetitia Ferdynus, Cyril Bocquet, Valery Sauvat, Frederique |
author_sort | Harper, Luke |
collection | PubMed |
description | OBJECTIVE: Boys with posterior urethral valves (PUV) present an increased risk of febrile urinary tract infection (fUTI). Identifying specific risk factors could allow for tailoring UTI prevention. The aim of this study was to use the data from the CIRCUP randomized controlled trial data to identify patient characteristics associated with a higher risk of fUTI. PATIENTS AND METHODS: We performed a secondary analysis of the data from the CIRCUP randomized trial which included boys with PUV, randomized to circumcision and antibiotic prophylaxis vs. antibiotic prophylaxis alone and followed for 2 years. There was only 1 episode of fUTI in the circumcision group vs. 17 in the uncircumcised group. We therefore only studied the antibiotic prophylaxis alone group and compared age at prenatal diagnosis, size and weight at birth, presence of dilating VUR at diagnosis, abnormal DMSA scan at 2 months, and nadir creatinine between children who presented a fUTI and those who did not, as well as age at first episode of fUTI. RESULTS: The study group consisted of 42 patients of which 17 presented at least on fUTI. Presence of dilating VUR was significantly associated with risk of fUTI (p = 0.03), OR: 6 [CI 95% = (1.13–27.52)]. None of the other parameters were associated with increased risk of fUTI. We observed three distinct time periods for presenting a fUTI with a decrease in infection rate after the first 40 days of life, then at 240 days of life. CONCLUSION: In boys with PUV, presence of high-grade VUR is associated with a higher risk of presenting a fUTI. The rate of febrile UTIs seems to decrease after 9 months. |
format | Online Article Text |
id | pubmed-9515483 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95154832022-09-29 Risk factors for febrile urinary tract infection in boys with posterior urethral valves Harper, Luke Botto, Nathalie Peycelon, Matthieu Michel, Jean-Luc Leclair, Marc-David Garnier, Sarah Clermidi, Pauline Arnaud, Alexis P. Dariel, Anne-Laure Dobremez, Eric Faure, Alice Fourcade, Laurent Boudaoud, Nadia Chaussy, Yann Collin, Fideline Huiart, Laetitia Ferdynus, Cyril Bocquet, Valery Sauvat, Frederique Front Pediatr Pediatrics OBJECTIVE: Boys with posterior urethral valves (PUV) present an increased risk of febrile urinary tract infection (fUTI). Identifying specific risk factors could allow for tailoring UTI prevention. The aim of this study was to use the data from the CIRCUP randomized controlled trial data to identify patient characteristics associated with a higher risk of fUTI. PATIENTS AND METHODS: We performed a secondary analysis of the data from the CIRCUP randomized trial which included boys with PUV, randomized to circumcision and antibiotic prophylaxis vs. antibiotic prophylaxis alone and followed for 2 years. There was only 1 episode of fUTI in the circumcision group vs. 17 in the uncircumcised group. We therefore only studied the antibiotic prophylaxis alone group and compared age at prenatal diagnosis, size and weight at birth, presence of dilating VUR at diagnosis, abnormal DMSA scan at 2 months, and nadir creatinine between children who presented a fUTI and those who did not, as well as age at first episode of fUTI. RESULTS: The study group consisted of 42 patients of which 17 presented at least on fUTI. Presence of dilating VUR was significantly associated with risk of fUTI (p = 0.03), OR: 6 [CI 95% = (1.13–27.52)]. None of the other parameters were associated with increased risk of fUTI. We observed three distinct time periods for presenting a fUTI with a decrease in infection rate after the first 40 days of life, then at 240 days of life. CONCLUSION: In boys with PUV, presence of high-grade VUR is associated with a higher risk of presenting a fUTI. The rate of febrile UTIs seems to decrease after 9 months. Frontiers Media S.A. 2022-09-14 /pmc/articles/PMC9515483/ /pubmed/36186628 http://dx.doi.org/10.3389/fped.2022.971662 Text en Copyright © 2022 Harper, Botto, Peycelon, Michel, Leclair, Garnier, Clermidi, Arnaud, Dariel, Dobremez, Faure, Fourcade, Boudaoud, Chaussy, Collin, Huiart, Ferdynus, Bocquet and Sauvat. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pediatrics Harper, Luke Botto, Nathalie Peycelon, Matthieu Michel, Jean-Luc Leclair, Marc-David Garnier, Sarah Clermidi, Pauline Arnaud, Alexis P. Dariel, Anne-Laure Dobremez, Eric Faure, Alice Fourcade, Laurent Boudaoud, Nadia Chaussy, Yann Collin, Fideline Huiart, Laetitia Ferdynus, Cyril Bocquet, Valery Sauvat, Frederique Risk factors for febrile urinary tract infection in boys with posterior urethral valves |
title | Risk factors for febrile urinary tract infection in boys with posterior urethral valves |
title_full | Risk factors for febrile urinary tract infection in boys with posterior urethral valves |
title_fullStr | Risk factors for febrile urinary tract infection in boys with posterior urethral valves |
title_full_unstemmed | Risk factors for febrile urinary tract infection in boys with posterior urethral valves |
title_short | Risk factors for febrile urinary tract infection in boys with posterior urethral valves |
title_sort | risk factors for febrile urinary tract infection in boys with posterior urethral valves |
topic | Pediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515483/ https://www.ncbi.nlm.nih.gov/pubmed/36186628 http://dx.doi.org/10.3389/fped.2022.971662 |
work_keys_str_mv | AT harperluke riskfactorsforfebrileurinarytractinfectioninboyswithposteriorurethralvalves AT bottonathalie riskfactorsforfebrileurinarytractinfectioninboyswithposteriorurethralvalves AT peycelonmatthieu riskfactorsforfebrileurinarytractinfectioninboyswithposteriorurethralvalves AT micheljeanluc riskfactorsforfebrileurinarytractinfectioninboyswithposteriorurethralvalves AT leclairmarcdavid riskfactorsforfebrileurinarytractinfectioninboyswithposteriorurethralvalves AT garniersarah riskfactorsforfebrileurinarytractinfectioninboyswithposteriorurethralvalves AT clermidipauline riskfactorsforfebrileurinarytractinfectioninboyswithposteriorurethralvalves AT arnaudalexisp riskfactorsforfebrileurinarytractinfectioninboyswithposteriorurethralvalves AT darielannelaure riskfactorsforfebrileurinarytractinfectioninboyswithposteriorurethralvalves AT dobremezeric riskfactorsforfebrileurinarytractinfectioninboyswithposteriorurethralvalves AT faurealice riskfactorsforfebrileurinarytractinfectioninboyswithposteriorurethralvalves AT fourcadelaurent riskfactorsforfebrileurinarytractinfectioninboyswithposteriorurethralvalves AT boudaoudnadia riskfactorsforfebrileurinarytractinfectioninboyswithposteriorurethralvalves AT chaussyyann riskfactorsforfebrileurinarytractinfectioninboyswithposteriorurethralvalves AT collinfideline riskfactorsforfebrileurinarytractinfectioninboyswithposteriorurethralvalves AT huiartlaetitia riskfactorsforfebrileurinarytractinfectioninboyswithposteriorurethralvalves AT ferdynuscyril riskfactorsforfebrileurinarytractinfectioninboyswithposteriorurethralvalves AT bocquetvalery riskfactorsforfebrileurinarytractinfectioninboyswithposteriorurethralvalves AT sauvatfrederique riskfactorsforfebrileurinarytractinfectioninboyswithposteriorurethralvalves |